Pharmazie 1990-10-01

[The stabilization of physostigmine salicylate injection solutions. 2].

D Trose, A Kässmann

Index: Pharmazie 45(10) , 783-5, (1990)

Full Text: HTML

Abstract

In a long term test covering 4 years the potency of stabilizing agents for 0.04% physostigmine salicylate (1) solutions was studied under thermal loading. Thereby complex stabilizers were used as well as simple stabilizing agents. The most effective stabilization was achieved with 0.1% ascorbic acid. The results of the 1th information concerning the stabilization of a 0.1% 1 injection solution with ascorbic acid over a period of one year were confirmed in a long term test for 0.04% 1 solutions. At the some time these long term tests confirmed the formulation as being established for the "Standard Formulas 1988". The stability tests were carried out spectrophotometricly by using the picrate method. Other methods mentioned in literature gave no satisfying reproducibility.


Related Compounds

Related Articles:

Possible interaction of cholinergic and GABAergic systems between MS and CA1 upon memory acquisition in rats.

2012-12-01

[Behav. Brain Res. 235(2) , 231-43, (2012)]

The effects of physostigmine infusion on patients with panic disorder.

1991-04-01

[Biol. Psychiatry 29(7) , 658-64, (1991)]

Development and optimization of a sublingual tablet formulation for physostigmine salicylate.

2009-09-01

[Acta. Pharm. 59(3) , 301-12, (2009)]

Liquid chromatographic analysis of physostigmine salicylate and its degradation products.

1999-01-01

[J. Pharm. Biomed. Anal. 18(6) , 939-45, (1999)]

Brain neurotransmitter systems mediating behavioral deficits produced by inescapable shock treatment in rats.

1988-04-26

[Brain Res. 447(1) , 122-32, (1988)]

More Articles...